TwinssCan - Gene-Environment Interaction in Psychotic and Depressive Intermediate Phenotypes: Risk and Protective Factors in a General Population Twin Sample.


Journal

Twin research and human genetics : the official journal of the International Society for Twin Studies
ISSN: 1832-4274
Titre abrégé: Twin Res Hum Genet
Pays: England
ID NLM: 101244624

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 12 11 2019
medline: 5 8 2020
entrez: 12 11 2019
Statut: ppublish

Résumé

Meta-analyses suggest that clinical psychopathology is preceded by dimensional behavioral and cognitive phenotypes such as psychotic experiences, executive functioning, working memory and affective dysregulation that are determined by the interplay between genetic and nongenetic factors contributing to the severity of psychopathology. The liability to mental ill health can be psychometrically measured using experimental paradigms that assess neurocognitive processes such as salience attribution, sensitivity to social defeat and reward sensitivity. Here, we describe the TwinssCan, a longitudinal general population twin cohort, which comprises 1202 individuals (796 adolescent/young adult twins, 43 siblings and 363 parents) at baseline. The TwinssCan is part of the European Network of National Networks studying Gene-Environment Interactions in Schizophrenia project and recruited from the East Flanders Prospective Twin Survey. The main objective of this project is to understand psychopathology by evaluating the contribution of genetic and nongenetic factors on subclinical expressions of dimensional phenotypes at a young age before the onset of disorder and their association with neurocognitive processes, such as salience attribution, sensitivity to social defeat and reward sensitivity.

Identifiants

pubmed: 31708010
pii: S1832427419000963
doi: 10.1017/thg.2019.96
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Twin Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

460-466

Auteurs

Lotta-Katrin Pries (LK)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Clara Snijders (C)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Claudia Menne-Lothmann (C)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Jeroen Decoster (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Neurosciences, University Psychiatric Centre KU Leuven, KU Leuven, Belgium.
Brothers of Charity, University Psychiatric Centre Sint-Kamillus Bierbeek, Bierbeek, Belgium.

Ruud van Winkel (R)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Neurosciences, University Psychiatric Centre KU Leuven, KU Leuven, Belgium.

Dina Collip (D)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Philippe Delespaul (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Marc De Hert (M)

Department of Neurosciences, University Psychiatric Centre KU Leuven, KU Leuven, Belgium.

Catherine Derom (C)

Centre of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Department of Obstetrics and Gynecology, Ghent University Hospitals, Ghent University, Ghent, Belgium.

Evert Thiery (E)

Department of Neurology, Ghent University Hospital, Ghent University, Ghent, Belgium.

Nele Jacobs (N)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Faculty of Psychology and Educational Sciences, Open University of the Netherlands, Heerlen, the Netherlands.

Marieke Wichers (M)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Sinan Guloksuz (S)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Psychiatry, Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, the Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, King's Health Partners, King's College London, London, UK.

Bart P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH